Lawyers as Leaders
Description:
Over the last thirty years, the concern of Pain Medicine practitioners about the potential for their patients to develop a dependence on opioids has left opioid therapy as a largely underutilized treatment. While there is no simple answer to chronic pain, opioids remain the only class of drugs capable of providing relief to patients experiencing serious pain. Opioid Therapy in the 21st Century, Second Edition fills a dearth of clinical knowledge about analgesics to aid practitioners in weighing the risks versus the benefits of opioid therapy for their chronic pain patients. This second edition provides updated information on recently approved opioids as well as approved indications for older opioids and clinical trials.
Part of the Oxford American Pain Library, this concise guide serves as a practical, accessible reference for physicians across the range of primary care and medical specialties. It includes an overview of appropriate clinical applications of opioids, covering such topics as opioid pharmacology, route selection, and individualization of therapy, as well as strategies for managing and mitigating the risk of abuse, addiction, and diversion. There are also special sections dedicated to the unique needs of pediatric, geriatric, and palliative care patient populations.
Best prices to buy, sell, or rent ISBN 9780199844975
Frequently Asked Questions about Lawyers as Leaders
The price for the book starts from $34.48 on Amazon and is available from 17 sellers at the moment.
If you’re interested in selling back the Lawyers as Leaders book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Lawyers as Leaders book, the best buyback offer comes from and is $ for the book in good condition.
The Lawyers as Leaders book is in very low demand now as the rank for the book is 1,676,366 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.